He had to take a break from his expensive migraine medications: – He must isolate himself in dark rooms in an inferno of pain.

ad

ad

Patients with chronic migraines are forced to take a break from an effective medication because health authorities think it is too expensive. Many politicians respond.

This applies to the so-called CGRP inhibitors that came out in 2019. Unlike many other drugs, this was very effective, NTB reports. So there was great excitement when it became available with a blue prescription.

Now, however, health authorities are clamping down on the drug’s use, and want patients to stop treatment for three months after 18 months of treatment, he writes. VG.

ad

– We must make sure that the drug is of sufficient benefit, the chief medical officer of the Norwegian Medicines Agency tells the newspaper Ingrid As.

Jana Middelvart Hoff, president of the Norwegian Society of Neurology, reacts strongly to the fact that patients should take a break.

Norwegian neurologists are very concerned about tightening regulations and believe this will bypass patients, often people who have struggled for years before getting something to help them, says Middelvart Hoff.

If you have to pay for the drug yourself, it will cost 5-6000 kroner for a spray dose per month. What health authorities pay for each dose is exempt from the public.

Many politicians are angry at the austerity measures. Rødt, SV and Frp sent questions about the case to Minister for Health and Welfare Services Ingvild Kjerkol (PT), and were not satisfied with the answer. The SV has now submitted a motion in the Norwegian Parliament calling for the tightening to be lifted.

We fear that people with severe migraines will have to isolate themselves in dark rooms in an inferno of pain, says Bård Hoksrud (Frp), who will support the proposal.

A young artist dares to admit that she reads Resett: – politically, the field of art is narrow and narrow-minded (+)